Company Valuation: BIONOMICSSADR

Data adjusted to current consolidation scope
Fiscal Period: June 2025 2026 2027 2028
Market Cap 1 20.36 27.18 - -
Change - 33.51% - -
Enterprise Value (EV) 20.36 27.18 27.18 27.18
Change - 33.51% 0% 0%
P/E -30.9x -0.86x -1.45x -1.43x
PBR - - - -
PEG - -0x 0x -1.16x
Capitalization / Revenue 0.86x - - -
EV / Revenue 0x - - -
EV / EBITDA -0x -1.2x -1.06x -0.9x
EV / EBIT -0x -1.2x -1.06x -0.9x
EV / FCF - - - -
FCF Yield - - - -
Dividend per Share 2 - - - -
Rate of return - - - -
EPS 2 -0.23 -4.07 -2.43 -2.46
Distribution rate - - - -
Net sales 1 23.79 - - -
EBITDA 1 -1.717 -22.66 -25.74 -30.08
EBIT 1 -1.717 -22.66 -25.74 -30.08
Net income 1 -0.562 -27 -24.06 -28.54
Net Debt - - - -
Reference price 2 7.100 3.520 3.520 3.520
Nbr of stocks (in thousands) 1,880 5,405 - -
Announcement Date 9/29/25 - - -
1AUD in Million2USD
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
35.1x6.14x18.98x0.94% 50.35B
-23.1x337.19x-21.24x-.--% 39.21B
25.17x2.79x12.05x-.--% 34.52B
46.88x4.72x30.24x-.--% 34.6B
27.13x7.96x19.97x0.42% 27.05B
31.25x5.03x22.91x-.--% 15.11B
24.07x2.05x9x1.11% 13.85B
24.32x1.93x11.7x-.--% 13.18B
Average 23.85x 45.98x 12.95x 0.31% 28.48B
Weighted average by Cap. 22.88x 62.03x 12.07x 0.32%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA